ARCHIVES

“What Is Good For NCI Is Good For NIH,” Broder Says In Address

This article is from The Cancer Letter archive.

Vol. 21 No. 02 | January 13, 1995

Download PDF Visit The Full Archive

Related Articles

OCC Proposes Plan To Educate Patients, Physicians On Value Of Clinical Trials

January 8, 1988

ODAC Recommends TICE BCG Approval For Recurrent Bladder Cancer Prevention

January 10, 1997

Tobacco Council Lists 14 Smoking-Health Awards

July 30, 1976

Diagnosis-Treatment Cidac contract Gets Recompetition Okay

December 16, 1983

FDA Approves Afinitor For Advanced Kidney Cancer

March 27, 2009

NCI-Approved Clinical Trials

January 27, 2006